Dias nummer 1 - PowerPoint PPT Presentation

1 / 47
About This Presentation
Title:

Dias nummer 1

Description:

Steen Ingwersen, Biomodellering, Novo Nordisk. ... Udviklingsomkostningerne for et nyt medikament ligger typisk mellem 1 og 7 milliarder kr. ... – PowerPoint PPT presentation

Number of Views:51
Avg rating:3.0/5.0
Slides: 48
Provided by: lmfk
Category:
Tags: dias | ligger | nummer

less

Transcript and Presenter's Notes

Title: Dias nummer 1


1
Matematik i biologi og farmaceutisk industri.
Årskursus i matematik, kemi og fysik, Rosborg
Gymnasium, Vejle, 24/10, 2008
Mads Peter Sørensen DTU Matematik, Kgs. Lyngby
  • Indhold
  • Udvikling af medicin og matematisk modellering.
  • Blodkoagulation.
  • Insulinproducerende beta celler.
  • Sammenfatning.

2
Samarbejdspartnere.
  • Nina Marianne Andersen, DTU Matematik og Novo
    Nordisk
  • Steen Ingwersen, Biomodellering, Novo Nordisk.
  • Ole Hvilsted Olsen, Hæmostasis biokemi, Novo
    Nordisk.
  • Morten Gram Pedersen, Department of Information
    Engineering, University of Padova, Italy.
  • Oleg V. Aslanidi, Institute of Cell Biophysics
    RAS, Pushchino, Moscow, Russia.
  • Oleg A. Mornev, Institute of Theoretical and
    Experimental Biophysics RAS, Pushchino, Moscow,
    Russia.
  • Ole Skyggebjerg, Novo Nordisk.
  • Per Arkhammar og Ole Thastrup, BioImage a/s,
    Søborg.
  • Alwyn C. Scott, DTU Informatik og University of
    Arizona, Tucson AZ, USA.
  • Peter L. Christiansen, DTU Fysik og DTU
    Informatik.
  • Knut Conradsen, DTU Informatik

Sponsorer Modelling, Estimation and Control of
Biotechnological Systems (MECOBS).
EU Network of Excellence BioSim.
3
Udviklingsomkostninger for ny medicin.
Ref. Erik Mosekilde, Ingeniøren 10. oktober,
side 9, (2008).
EU Network of Excellence BioSim.
http//biosim-network.eu
4
Udviklingsprocessen for ny medicin.
1) Opdagelse.
2) Prækliniske forsøg.
Ide, hypotese, forskning. Dyremodeller.
Dyreforsøg.
Udviklingsfase. Dyreforsøg. Protokol for
sikkerhed og effektivitet. Mekanisme og
potentiel giftpåvirkning af organer.
5
4) Godkendelse.
3) Kliniske forsøg.
Regulerende myndigheder. Godkendelse af
medikamentet. Marketing autorisation. Sikker og
effektiv medicin.
Godkendelse fra regulerende myndigheder. Test på
mennesker. Test for sikkerhed og
effektivitet. gt50 af udviklings tiden. 1 ud af
10-15 medikamenter overlever til fase 3
5) Kontrol.
Lægemiddelovervågning
6
Matematisk modellering som et redskab i
udviklingen af ny medicin
  • Udviklingsomkostningerne for et nyt medikament
    ligger typisk mellem 1 og 7 milliarder kr.
  • Udviklingstid 10 15 år.
  • Anvendelse af moderne modellerings og computer
    simuleringsværktøjer til udvikling af ny medicin.
    Kompleksitet.
  • Mere rationel og hurtigere udviklings proces
    med færre økonomiske omkostninger.
  • Forbedret behandling af patienter. Bedre, mere
    sikker og mere individuel behandling.
  • Reduktion i anvendelse af dyre eksperimenter.
  • Computer model af menneske.

7
Disorders of Coagulation
Hypercoagulation Cardiovascular
diseases Arthroscleroses Emboli and thrombi
development
  • Hypocoagulation
  • Hemophilia A
  • Hemophilia B
  • Others

8
Cartoon of the blood coagulation pathway.
Ref http//www.ambion.com/tools/pathway/pathway.p
hp?pathwayBlood20Coagulation20Cascade
9
Perfusions eksperiment og modellering
Perfusions kammer
Aktive thrombocyter (Ta) binder til et collagen
coated låg. vWF.
Glaslåg coated med collagen
Faktor X i fluid fase X
Thrombocyter (blodplader), røde og hvide blod
celler.
Faktor VIIa I fluid fase VIIa
Rekonstrueret blod. Indhold Thrombocyter (T),
Erythrocyter. T 14 nM (70,000 blodplader / µ
litre blood)
10
Enzym kinetic
Reaktions skema
Reaktions ligningerne
Bemærk at
11
Enzym kinetic
Skalering
Matematisk model
Kvasistationær tilstand
Ref. J. Keener and J. Sneyd, Mathematical
Physiology, Springer, New York, (1998). M.G.
Pedersen, A.M. Bersani and E. Bersani, Jour. of
Math. Chem. 43(4), pp1318-1344, (2008).
12
Konkurrerende inhibitor (hæmningsstof)
Reaktions skema
Inklusion af flow og diffusion
Diffusionskonstant
Konvektions flow hastighed
Reaktionsskema ved rand
Bindingssites på rand
13
To dimensionalt eksempel med flow, diffusion og
bindingssites på randen
Bindingssites på randen
14
Cartoon model of the perfusion experiment
Unactivated Platelet
Activated Platelet
IIa
IIa
II
IIa
VaXa
V
VIIa
Xa
X
Va
Activated Platelet
15
Reaction schemes, one example.
Factor II (prothrombin) II Factor IIa
(thrombin) IIa Prothrombinase complex Xa_Va_Ta
A total of 17 equations.
Reaction rates
Ref P.M. Didriksen, Modelling hemostasis - a
biosimulation project, internal report, Dept. 252
Biomodelling, Novo Nordisk
16
Numerical results.
Initial conditions FVIIa 50 nM FX 170 nM T
14 nM sTa 0.114 nM FII 0.3 nM
IIa
T
VIIa
Ta
17
Reaction diffusion model with convection
Reaction scheme for T, Ta and IIa.
Corresponding model equations in the space O.
Poiseuilles flow
18
Boundary conditions and parameters
Boundary condition x0
Boundary condition xl Outflow boundary
conditions. Top and bottom boundary condition No
flow crossing.
Ref. M. Anand, K. Rajagopal, K.R. Rajagopal. A
Model Incorporating some of the Mechanical and
Biochemical Factors Underlying Clot Formation and
Dissolution in Flowing Blood. Journal of
Theoretical Medicine, 5 183-218, 2003.
19
Numerical results.
Time 0.6 sec.
IIa
T
T-IIa
Ta
20
Numerical results.
Time 5 sec.
T
IIa
T-IIa
Ta
21
Numerical results.
Time 10 sec.
T
IIa
T-IIa
Ta
22
Future work Boundary attachment of Ta
Reaction schemes on
Corresponding model equations on.
23
Including pro-coagulant and anti-coagulant
thrombin
Ref. V.I. Zarnitsina et al, Dynamics of
spatially nonuniform patterning in the model of
blood coagulation, Chaos 11(1), pp57-70,
2001. E.A. Ermakova et al, Blood coagulation and
propagation of autowaves in flow, Pathophysiology
og Haemostasis and Thrombosis, 34, pp135-142,
2005.
24
Model consisting of 11 PDEs in 21 D, including
diffusion
25
Sammenfatning og fremtidig arbejde
  • Modellering af perfusionseksperiment for
    blod-koagulation.
  • Reduceret PDL model, som inkludere blod flow og
    diffusion.
  • Modellering af vedhæftning af aktive thrombocyter
    på collagen coated rand.
  • Fuld PDL model.
  • Model af in vivo blod koagulation.

26
Synthesis and secretion of insulin
Transcription
Pre-proinsulin
Insulin Golgi complex packed in granules
Proinsulin Endoplasmatic reticulum
B
Exocytosis of insulin caused by increased Ca
concentration
27
The ß-cell
Ion channel gates for Ca and K
B
28
Mathematical model for single cell dynamics
The modified Hodgkin-Huxley model for a single
ß-cell
Ion currents due to the ion-gates
Ref. A. Sherman, (Eds. Othmar et al), Case
studies in mathematical modelling, ecology
physiology and cell biology, Prentice Hall
(1996), pp.199-217. Ref. Fall, Marland, Wagner,
Tyson, Computational Cell Biology, Springer,
(2002).
29
Mathematical model for single cell dynamics
The gating variables
Ref. Fall, Marland, Wagner, Tyson, Computational
Cell Biology, Springer, (2002).
30
Ref. Fall, Marland, Wagner, Tyson, Computational
Cell Biology, Springer, (2002).
31
Dynamics and bifurcations
Ref. E.M. Izhikevich, Neural excitability
spiking and bursting, Int. Jour. of Bifurcation
and Chaos, p1171 (2000).
32
Dynamics and bifurcations
Simple polynomial model
Parameters
Ref. J. Keener and J. Sneyd, Mathematical
Physiology, Springer, New York, (1998).
33
Sketch of the homoclinic bifurcation
34
Mathematical model for single cell dynamics
Topologically equivalent and simplified models.
Polynomial model with Gaussian noise term on
the gating variable.
Voltage across the cell membrane
Gating variable
Slow gate variable
Gaussian gate noise term
where
Ref. M. Panarowski, SIAM J. Appl. Math., 54
pp.814-832, (1994).
Ref. A. Sherman, (Eds. Othmar et al), Case
studies in mathematical modelling, ecology
physiology and cell biology, Prentice Hall
(1996), pp.199-217.
35
The influence of noise on the beta-cell bursting
phenomenon.
Ref. M.G. Pedersen and M.P. Sørensen, SIAM J.
Appl. Math., 67(2), pp.530-542, (2007).
36
Mathematical model for coupled ß-cells
Gap junctions between neighbouring cells
Coupling to nearest neighbours.
Coupling constant
Ref. A. Sherman, (Eds. Othmar et al), Case
studies in mathematical modelling, ecology
physiology and cell biology, Prentice Hall
(1996), pp.199-217.
37
Coupled ß-cells
Image analysis experiments of in vitro islets of
Langerhans
38
Experiments on Islets of Langerhans
39
The gating variables
Calcium current
Potassium current
ATP regulated potassium current
Slow ion current
The gating variables obey.
40
Glycose gradients through Islets of Langerhans
Ref. J.V. Rocheleau, et al, Microfluidic glycose
stimulations , PNAS, vol 101 (35), p12899
(2004).
41
Glycose gradients through Islets of Langerhans.
Model.
Continuous spiking for
Bursting for
Silence for
Coupling constant
Note that
corresponds to
42
Wave blocking
Units
43
Glycose gradients through Islets of Langerhans
44
PDE model. Fishers equation
Continuum limit of
Is approximated by the Fishers equation
where
Velocity
Simple kink solution
Ref. O.V. Aslanidi et.al. Biophys. Jour. 80, pp
1195-1209, (2001).
45
Numerical simulations and comparison to analytic
result
46
Sammenfatning
  • Støj på ion porte reducerer burst perioden.
  • Blokering af bølgeudbredelse ved rumlig variation
    af den ATP regulerende Na ion kanal.
  • Koblingen mellem beta celler fører til en forøget
    excitation af ellers inaktive celler.

Ref. M.G. Pedersen and M.P. Sørensen, SIAM J.
Appl. Math., 67(2), pp.530-542, (2007). M.G.
Pedersen and M.P. Sørensen, To appear in Jour. of
Bio. Phys. Special issue on Complexity in
Neurology and Psychiatry, (2008).
  • Bio-kemiske processer er meget komplekse og
    kræver omfattende modellering.
  • Simple og overskuelige modeller kan give
    kvalitativ indsigt.
  • Der er lang vej til pålidelige kvantitative
    modeller.
  • Matematiske modeller forventes dog at kunne
    bidrage til hurtigere og mere sikker udvikling af
    medicin med færre dyreforsøg.

47
Studieretningsprojekter for gymnasiet
Se
http//www.dtu.dk/Moed_DTU/Studieretningsprojekter
.aspx
Write a Comment
User Comments (0)
About PowerShow.com